# Incentives and Long-Acting Injectable Adherence After Involuntary Hospitalization

> **NCT07130500** · NA · ENROLLING_BY_INVITATION · sponsor: **Stanford University** · enrollment: 1000 (estimated)

## Conditions studied

- Schizophrenia Disorder
- Schizoaffective Disorder
- Bipolar Disorder (BD)
- Substance Use Disorder (SUD)

## Interventions

- **BEHAVIORAL:** Financial incentives for adherence to long-acting injectable medication
- **BEHAVIORAL:** Standard of care with monthly surveys

## Key facts

- **NCT ID:** NCT07130500
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-03-09
- **Primary completion:** 2029-03
- **Final completion:** 2030-03
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-03-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07130500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07130500, "Incentives and Long-Acting Injectable Adherence After Involuntary Hospitalization". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07130500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
